In our study, the concentrations of TF+/CD20+ EVs and TF− DLBCL/B-cell EVs (CD19, CD20, CD45) were significantly higher in DLBCL patients than in healthy controls. The gene discussed is TF; the disease is diffuse large B-cell lymphoma.